Home � Products & Services � Benchmarking Reports � Medical Affairs � Medical Communication

Improving Medical Affairs Booth Impact at Oncology Congresses

Download FREE Excerpt

ID: POP-407

Features:

15 Info Graphics

20 Data Graphics

380+ Metrics

12 Narratives

Pages: 43

Published: 2025

Delivery Format: Shipped

License Options:
$6000 - 1 user
$18000 - Up to 5 users
$30000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Medical Affairs booths at Oncology congresses serve as critical platforms for educating key stakeholders about breakthrough therapies and the latest advancements in cancer treatment. However, maximizing engagement in a highly competitive congress environment requires innovative booth strategies, effective scientific content dissemination, and compliance with evolving regulatory standards.

Best Practices, LLC conducted this benchmarking research to analyze how leading biopharma companies effectively build out their Medical Affairs booths to maximize impact at Oncology congresses and afterwards. This report provides insights into best practices for booth design, content presentation, and HCP engagement strategies, empowering Medical Affairs teams to strengthen their scientific presence and optimize booth effectiveness.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care

Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 20 Medical Communications and Scientific Publications leaders from 17 biopharma companies for this research project. While the overall research provides broad industry insights, the oncology-specific analysis is based on data from 7 biopharma companies actively involved in oncology congresses. The research employed a quantitative survey as the primary method of data collection, enriched with qualitative insights to highlight industry-leading strategies and emerging trends.

Key topics covered in this report include:

Best Practices for Medical Affairs Booth Content at Oncology Congresses
Effective Display Methods for Oncology Booth Content
Regional Content Adaptation for US, EU, and Global Oncology Congresses
Performance Metrics and Success Indicators for Oncology Booths
Enhancing Poster/Investigator Events to Drive Scientific Dialogue in Oncology
Innovative MSL Content Strategies for Oncology-Focused Scientific Exchange

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Interactive Elements at Oncology Booths: Animated educational videos at booths have the highest value; new VR technology and games are nascent efforts to improve learning experience.

Table of Contents

Sr. No.	Topic	Slide No.
I.�	Executive Summary	Pg. 4
II.�	Medical Affairs Booth Content and Information Availability, Display Tactics	Pg. 9
III.�	Best Practices of Medical Affairs Booth Activities, Performance Measurements	Pg. 22
IV.�	Company-Hosted Poster/Investigator Events at Congresses	Pg. 29
V.�	Innovative MSL Content Sharing and Participation in Congress Events	Pg. 33
VI.�	Benchmark Demographics	Pg. 40
VII.�	About Best Practices, LLC	Pg. 43

List of Charts & Exhibits

I. Executive Summary

Medical booth impact at oncology congresses: Research overview, objectives, methodology, and topics
Benchmark study partners
Study definitions and segmentation
Key study findings for maximizing oncology booth effectiveness

II. Medical Affairs Booth Content and Information Availability, Display Tactics

Top 5 booth content types shared per display method at oncology congresses
Types of content shared and displayed at oncology-focused medical booths
Interview narrative on the prerequisites for an oncology booth
Interview narrative around key factors influencing content display at oncology medical booths
Most important factors affecting content selection for oncology congress booths
Content types and formats available at virtual booths for oncology-focused congresses
Interview narrative around using technology to enhance booth engagement
Most valuable interactive elements for enhancing the learning experience at oncology-focused medical booths
Interview narrative around effectiveness of interactive games
Differentiation of oncology medical booth information across US, EU, APAC, and other regions
Interview narratives on adapting oncology congress booth content for regional audiences

III. Best Practices of Medical Affairs Booth Activities, Performance Measurements

Effective strategies to attract and engage attendees at oncology medical booths
Metrics for evaluating booth content impact and effectiveness at oncology congresses
Comparison of most valuable vs. widely-used metrics for oncology booth performance measurement
Channels used to distribute posters or congress content to attendees
Top practices for optimizing oncology-focused medical booth content and display
Common challenges and pitfalls in oncology booth content presentation and engagement

IV. Company-Hosted Poster/Investigator Events at Congresses

Hosting poster/investigator receptions at oncology congresses and content utilization
Re-use of previous oncology congress content at poster receptions and material lifespan
Restrictions on poster/investigator reception attendance at oncology-focused congresses

V. Innovative MSL Content Sharing and Participation in Congress Events

Materials used by MSL teams in the field and sharing methods (proactive vs. reactive)
Content availability and sharing methods at oncology congresses
Adoption of innovative MSL materials
Sharing innovative MSL materials
MSL utilization of poster books in oncology-related field discussions
MSL-hosted receptions at oncology medical congresses and attendee eligibility